June 2, 2026 New cancer vaccine delivers stunning result against one of the deadliest skin cancers A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer recurrence or death by nearly half.
May 29, 2026 Single infusion of controversial drug changed severe depression symptoms within hours, study finds Researchers say a single intravenous ketamine infusion can rapidly relieve severe depression and suicidal thoughts when traditional antidepressants fail.
May 26, 2026 Ozempic-style drugs linked to major slowdown in cancer spread, new study finds A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers, including lung cancer.
May 25, 2026 Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say Researchers say an experimental Alzheimer's drug may calm brain inflammation linked to alcohol withdrawal, potentially reducing relapse and neural damage.
May 21, 2026 ‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.
May 20, 2026 New obesity treatment may help preserve muscle during weight loss Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.
May 20, 2026 New drug approach offers hope for patients with recurrent aggressive cancers Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
May 18, 2026 New pancreatic cancer pill nearly doubles survival time in breakthrough trial A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
May 15, 2026 Cancer-related brain fog may improve with 2 simple treatments, scientists say Low-dose ibuprofen combined with home exercise could help cancer patients manage chemo brain, according to a new University of Rochester study finds.
May 14, 2026 Experimental obesity drug outperforms traditional weight-loss treatments in early research An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a study published in Nature.